L.J. Altfest & Co’s Abiomed Inc ABMD Stock Holding History

L.J. Altfest & Co’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,196	Closed	-$312K	–	198
2019 Q2	$312K	Buy	+1,196	New	+$317K	0.08%	137

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

L.J. Altfest & Co's ABMD Position: Q3 2019 in Review

L.J. Altfest & Co sold out of Abiomed Inc (ABMD) in Q3 2019, closing a stake of 1,196 shares — an estimated $312K sold.

L.J. Altfest & Co first reported a position in ABMD in Q2 2019 and held it in 1 quarter. The position peaked at $312K in Q2 2019. 443 funds tracked by Wall St. Rank hold ABMD as of Q3 2019.

L.J. Altfest & Co reported no remaining Abiomed Inc position as of Q3 2019 after selling out during the quarter.
L.J. Altfest & Co sold 1,196 Abiomed Inc shares in Q3 2019, an estimated $312K.
L.J. Altfest & Co first reported a position in Abiomed Inc in Q2 2019 and held it in 1 quarter.
L.J. Altfest & Co's Abiomed Inc position peaked at $312K in Q2 2019.
443 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2019.

Based on L.J. Altfest & Co's 13F filing for Q3 2019, filed 10 Oct 2019.